{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"11.660","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"396,277,305","primaryexch":"香港交易所","ric":"1541.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BMH6V56","am":"17.21","iv":"","ew_strike":"","as":"11.480","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"11.330","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2025-09-28 00:06:03.0","lo52":"4.310","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"田文志","underlying_ric":"1541.HK","hi52":"15.680","issuer_name":"宜明昂科生物醫藥技術(上海)股份有限公司 - B - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"10.820","mkt_cap":"4.48","f_aum_hkd":null,"ew_sub_per_to":"","ls":"11.330","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"+0.180","aum":"","issued_shares_class_B":null,"vo":"1.51","secondary_listing_flag":false,"listing_date":"2023年9月5日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"宜明昂科生物醫藥技術(上海)股份有限公司 - B - H股","nm_s":"宜明昂科－Ｂ","sym":"1541","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"宜明昂科生物醫藥技術（上海）股份有限公司是一家主要從事開發腫瘤免疫療法的中國公司。該公司的主要業務包括開髮用於系統利用先天性和適應性免疫的生物技術，以及開發下一代腫瘤免疫療法，免疫療法主要專注於適應性免疫系統。該公司主要在中國國內和海外市場開展業務。","op":"11.150","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國上海市<br/>浦東新區<br/>中國（上海）自由貿易試驗區<br/>張衡路1000弄15號樓","pc":"+1.61","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"11.150","isin":"CNE100006624","moneyness":""}},"qid":"1759074336266"}
